Acetylation	O
and	O
modulation	O
of	O
erythroid	B-protein
Kruppel-like	I-protein
factor	I-protein
(	O
EKLF	B-protein
)	O
activity	O
by	O
interaction	O
with	O
histone	B-protein
acetyltransferases	I-protein
.	O

Erythroid	B-protein
Kruppel-like	I-protein
factor	I-protein
(	O
EKLF	B-protein
)	O
is	O
a	O
red	B-protein
cell-specific	I-protein
transcriptional	I-protein
activator	I-protein
that	O
is	O
crucial	O
for	O
consolidating	O
the	O
switch	O
to	O
high	O
levels	O
of	O
adult	O
beta-globin	B-protein
expression	O
during	O
erythroid	O
ontogeny	O
.	O

EKLF	B-protein
is	O
required	O
for	O
integrity	O
of	O
the	O
chromatin	O
structure	O
at	O
the	O
beta-like	B-DNA
globin	I-DNA
locus	I-DNA
,	O
and	O
it	O
interacts	O
with	O
a	O
positive-acting	B-protein
factor	I-protein
in	O
vivo	O
.	O

We	O
find	O
that	O
EKLF	B-protein
is	O
an	O
acetylated	B-protein
transcription	I-protein
factor	I-protein
,	O
and	O
that	O
it	O
interacts	O
in	O
vivo	O
with	O
CBP	B-protein
,	O
p300	B-protein
,	O
and	O
P/CAF	B-protein
.	O

However	O
,	O
its	O
interactions	O
with	O
these	O
histone	B-protein
acetyltransferases	I-protein
are	O
not	O
equivalent	O
,	O
as	O
CBP	B-protein
and	O
p300	B-protein
,	O
but	O
not	O
P/CAF	B-protein
,	O
utilize	O
EKLF	B-protein
as	O
a	O
substrate	O
for	O
in	O
vitro	O
acetylation	O
within	O
its	O
trans-	O
activation	B-protein
region	I-protein
.	O

The	O
functional	O
effects	O
of	O
these	O
interactions	O
are	O
that	O
CBP	B-protein
and	O
p300	B-protein
,	O
but	O
not	O
P/CAF	B-protein
,	O
enhance	O
EKLF	B-protein
's	O
transcriptional	O
activation	O
of	O
the	O
beta-globin	B-DNA
promoter	I-DNA
in	O
erythroid	B-cell_type
cells	I-cell_type
.	O

These	O
results	O
establish	O
EKLF	B-protein
as	O
a	O
tissue-specific	B-protein
transcription	I-protein
factor	I-protein
that	O
undergoes	O
post-translational	O
acetylation	O
and	O
suggest	O
a	O
mechanism	O
by	O
which	O
EKLF	B-protein
is	O
able	O
to	O
alter	O
chromatin	B-DNA
structure	O
and	O
induce	O
beta-globin	B-protein
expression	O
within	O
the	O
beta-like	B-DNA
globin	I-DNA
cluster	I-DNA
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

95	NULL
,	NULL
pp	NULL
.	NULL

9855-9860	NULL
,	NULL
August	NULL
1998	NULL
Biochemistry	NULL
Acetylation	NULL
and	NULL
modulation	NULL
of	NULL
erythroid	NULL
Kriippel-like	NULL
factor	NULL
(	NULL
EKLF	NULL
)	NULL
activity	NULL
by	NULL
interaction	NULL
with	NULL
histone	NULL
acetyltransferases	NULL
WENJUN	NULL
ZHANG*	NULL
AND	NULL
JaAMEs	NULL
J	NULL
.	NULL

*Brookdale	NULL
Center	NULL
for	NULL
Molecular	NULL
Biology	NULL
and	NULL
*Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Mount	NULL
Sinai	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10029	NULL
Edited	NULL
by	NULL
Gary	NULL
Felsenfeld	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Diabetes	NULL
and	NULL
Digestive	NULL
and	NULL
Kidney	NULL
Diseases	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
,	NULL
and	NULL
approved	NULL
June	NULL
19	NULL
,	NULL
1998	NULL
(	NULL
received	NULL
for	NULL
review	NULL
April	NULL
23	NULL
,	NULL
1998	NULL
)	NULL
ABSTRACT	NULL
Erythroid	NULL
Kriippel-like	NULL
factor	NULL
(	NULL
EKLF	NULL
)	NULL
is	NULL
a	NULL
red	NULL
cell-specific	NULL
transcriptional	NULL
activator	NULL
that	NULL
is	NULL
crucial	NULL
for	NULL
consolidating	NULL
the	NULL
switch	NULL
to	NULL
high	NULL
levels	NULL
of	NULL
adult	NULL
3-globin	NULL
expression	NULL
during	NULL
erythroid	NULL
ontogeny	NULL
.	NULL

EKLF	NULL
is	NULL
required	NULL
for	NULL
integrity	NULL
of	NULL
the	NULL
chromatin	NULL
structure	NULL
at	NULL
the	NULL
-like	NULL
globin	NULL
locus	NULL
,	NULL
and	NULL
it	NULL
interacts	NULL
with	NULL
a	NULL
positive-acting	NULL
factor	NULL
in	NULL
vivo	NULL
.	NULL

We	NULL
find	NULL
that	NULL
EKLF	NULL
is	NULL
an	NULL
acetylated	NULL
transcription	NULL
factor	NULL
,	NULL
and	NULL
that	NULL
it	NULL
interacts	NULL
in	NULL
vivo	NULL
with	NULL
CBP	NULL
,	NULL
p300	NULL
,	NULL
and	NULL
P/CAF	NULL
.	NULL

However	NULL
,	NULL
its	NULL
interactions	NULL
with	NULL
these	NULL
histone	NULL
acetyltransferases	NULL
are	NULL
not	NULL
equivalent	NULL
,	NULL
as	NULL
CBP	NULL
and	NULL
p300	NULL
,	NULL
but	NULL
not	NULL
P/CAF	NULL
,	NULL
utilize	NULL
EKLF	NULL
as	NULL
a	NULL
substrate	NULL
for	NULL
in	NULL
vitro	NULL
acetylation	NULL
within	NULL
its	NULL
trans-activation	NULL
region	NULL
.	NULL

The	NULL
functional	NULL
effects	NULL
of	NULL
these	NULL
interactions	NULL
are	NULL
that	NULL
CBP	NULL
and	NULL
p300	NULL
,	NULL
but	NULL
not	NULL
P/CAF	NULL
,	NULL
enhance	NULL
EKLF	NULL
's	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
-globin	NULL
promoter	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
establish	NULL
EKLF	NULL
as	NULL
a	NULL
tissue-specific	NULL
transcription	NULL
factor	NULL
that	NULL
undergoes	NULL
post-translational	NULL
acetylation	NULL
and	NULL
suggest	NULL
a	NULL
mechanism	NULL
by	NULL
which	NULL
EKLF	NULL
is	NULL
able	NULL
to	NULL
alter	NULL
chromatin	NULL
structure	NULL
and	NULL
induce	NULL
{	NULL
-globin	NULL
expression	NULL
within	NULL
the	NULL
-like	NULL
globin	NULL
cluster	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
B-like	NULL
globin	NULL
cluster	NULL
relies	NULL
on	NULL
the	NULL
controlled	NULL
interplay	NULL
of	NULL
cellular	NULL
components	NULL
at	NULL
a	NULL
number	NULL
of	NULL
levels	NULL
during	NULL
erythroid	NULL
ontogeny	NULL
(	NULL
1-7	NULL
)	NULL
.	NULL

First	NULL
,	NULL
the	NULL
appropriate	NULL
combination	NULL
of	NULL
general	NULL
and	NULL
cell-specific	NULL
DNA-binding	NULL
factors	NULL
directs	NULL
transcription	NULL
in	NULL
a	NULL
tissue-	NULL
and	NULL
developmental-specific	NULL
fashion	NULL
.	NULL

Second	NULL
,	NULL
these	NULL
transcriptional	NULL
controls	NULL
are	NULL
placed	NULL
within	NULL
a	NULL
chromatin	NULL
context	NULL
that	NULL
itself	NULL
exhibits	NULL
tissue-	NULL
and	NULL
developmental-specific	NULL
changes	NULL
in	NULL
structure	NULL
.	NULL

Structural	NULL
analyses	NULL
of	NULL
the	NULL
locus	NULL
,	NULL
genetic	NULL
analyses	NULL
of	NULL
relevant	NULL
hemoglobinopathies	NULL
,	NULL
the	NULL
isolation	NULL
of	NULL
red	NULL
cell-specific	NULL
transcriptional	NULL
players	NULL
,	NULL
and	NULL
the	NULL
ability	NULL
to	NULL
reproduce	NULL
correct	NULL
tissue	NULL
and	NULL
developmental	NULL
regulation	NULL
of	NULL
the	NULL
fB-like	NULL
globin	NULL
cluster	NULL
in	NULL
transgenic	NULL
mice	NULL
have	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
cis-	NULL
and	NULL
trans-acting	NULL
components	NULL
that	NULL
act	NULL
together	NULL
to	NULL
accomplish	NULL
this	NULL
feat	NULL
.	NULL

However	NULL
,	NULL
the	NULL
molecular	NULL
details	NULL
of	NULL
how	NULL
such	NULL
exquisite	NULL
long-range	NULL
regulation	NULL
is	NULL
attained	NULL
are	NULL
far	NULL
from	NULL
resolved	NULL
,	NULL
although	NULL
recent	NULL
studies	NULL
of	NULL
protein-protein	NULL
interactions	NULL
and	NULL
the	NULL
use	NULL
of	NULL
compound	NULL
homozygous	NULL
mice	NULL
have	NULL
provided	NULL
some	NULL
additional	NULL
insights	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Erythroid	NULL
Kriippel-like	NULL
factor	NULL
(	NULL
EKLF	NULL
)	NULL
is	NULL
a	NULL
red	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
that	NULL
activates	NULL
the	NULL
B-globin	NULL
promoter	NULL
by	NULL
means	NULL
of	NULL
its	NULL
high-affinity	NULL
binding	NULL
to	NULL
the	NULL
CACCC	NULL
element	NULL
located	NULL
at	NULL
-90	NULL
(	NULL
9	NULL
)	NULL
.	NULL

It	NULL
contains	NULL
three	NULL
C2H2	NULL
zinc	NULL
fingers	NULL
that	NULL
discriminate	NULL
between	NULL
CACCC	NULL
elements	NULL
present	NULL
at	NULL
erythroid	NULL
promoters	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Its	NULL
preferential	NULL
binding	NULL
to	NULL
the	NULL
adult	NULL
B	NULL
CACCC	NULL
element	NULL
over	NULL
the	NULL
elements	NULL
at	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
embryonic	NULL
(	NULL
#	NULL
)	NULL
or	NULL
human	NULL
fetal	NULL
(	NULL
y	NULL
)	NULL
globin	NULL
genes	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
EKLF	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
developmental	NULL
switch	NULL
from	NULL
embryonic/fetal	NULL
to	NULL
adult	NULL
globin	NULL
expression	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Molecular	NULL
and	NULL
genetic	NULL
analyses	NULL
verified	NULL
that	NULL
EKLF	NULL
is	NULL
absolutely	NULL
critical	NULL
for	NULL
the	NULL
onset	NULL
in	NULL
expression	NULL
of	NULL
the	NULL
adult	NULL
B-globin	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
National	NULL
Academy	NULL
of	NULL
Sciences	NULL
0027-8424/98/959855-6	NULL
$	NULL
2.00/0	NULL
PNAS	NULL
is	NULL
available	NULL
online	NULL
at	NULL
www.pnas.org	NULL
.	NULL

9855	NULL
gene	NULL
,	NULL
as	NULL
homozygous	NULL
EKLF-null	NULL
mice	NULL
die	NULL
at	NULL
the	NULL
time	NULL
of	NULL
the	NULL
switch	NULL
to	NULL
adult	NULL
expression	NULL
because	NULL
of	NULL
a	NULL
profound	NULL
B-thalasse-mia	NULL
,	NULL
and	NULL
EKLF-null	NULL
embryonic	NULL
stem	NULL
cells	NULL
do	NULL
not	NULL
contribute	NULL
to	NULL
the	NULL
red	NULL
cell	NULL
population	NULL
in	NULL
chimeric	NULL
mice	NULL
(	NULL
12-15	NULL
)	NULL
.	NULL

However	NULL
,	NULL
further	NULL
analyses	NULL
of	NULL
EKLF-null	NULL
mice	NULL
,	NULL
particularly	NULL
after	NULL
crossing	NULL
with	NULL
a	NULL
mouse	NULL
line	NULL
that	NULL
contained	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
human	NULL
B-like	NULL
globin	NULL
locus	NULL
,	NULL
revealed	NULL
not	NULL
only	NULL
that	NULL
human	NULL
-globin	NULL
transcripts	NULL
were	NULL
absent	NULL
from	NULL
the	NULL
mouse	NULL
fetal	NULL
liver	NULL
but	NULL
also	NULL
that	NULL
y-globin	NULL
transcripts	NULL
were	NULL
5-fold	NULL
higher	NULL
and	NULL
persisted	NULL
beyond	NULL
the	NULL
level	NULL
seen	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
EKLF	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
absence	NULL
of	NULL
EKLF	NULL
led	NULL
to	NULL
a	NULL
complete	NULL
lack	NULL
of	NULL
DNase-hypersensitive	NULL
site	NULL
formation	NULL
at	NULL
both	NULL
the	NULL
transgenic	NULL
and	NULL
endogenous	NULL
B-globin	NULL
promoters	NULL
,	NULL
and	NULL
diminution	NULL
of	NULL
HS3	NULL
at	NULL
the	NULL
globin	NULL
locus	NULL
control	NULL
region	NULL
(	NULL
LCR	NULL
)	NULL
(	NULL
17	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
EKLF	NULL
is	NULL
a	NULL
major	NULL
player	NULL
in	NULL
activating	NULL
adult	NULL
B-globin	NULL
expression	NULL
,	NULL
not	NULL
only	NULL
by	NULL
its	NULL
transcriptional	NULL
activation	NULL
properties	NULL
but	NULL
also	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
generate	NULL
the	NULL
proper	NULL
chromatin	NULL
configuration	NULL
within	NULL
part	NULL
of	NULL
the	NULL
B-like	NULL
globin	NULL
locus	NULL
and	NULL
thus	NULL
facilitate	NULL
the	NULL
silencing	NULL
of	NULL
the	NULL
y-globin	NULL
promoter	NULL
.	NULL

Part	NULL
of	NULL
these	NULL
effects	NULL
are	NULL
likely	NULL
because	NULL
of	NULL
the	NULL
EKLF	NULL
transactivation	NULL
domain	NULL
,	NULL
which	NULL
bears	NULL
no	NULL
homology	NULL
to	NULL
other	NULL
proteins	NULL
but	NULL
is	NULL
proline	NULL
rich	NULL
and	NULL
is	NULL
required	NULL
for	NULL
cell-	NULL
and	NULL
promoter-specific	NULL
inducible	NULL
expression	NULL
(	NULL
18	NULL
)	NULL
.	NULL

This	NULL
domain	NULL
is	NULL
multipartite	NULL
,	NULL
containing	NULL
a	NULL
cis-acting	NULL
inhibitory	NULL
domain	NULL
next	NULL
to	NULL
the	NULL
zinc	NULL
fingers	NULL
,	NULL
and	NULL
a	NULL
minimal	NULL
activation	NULL
domain	NULL
that	NULL
,	NULL
by	NULL
in	NULL
vivo	NULL
competition	NULL
analyses	NULL
,	NULL
overlaps	NULL
the	NULL
EKLF	NULL
trans-acting	NULL
interaction	NULL
domain	NULL
(	NULL
19	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
revealed	NULL
that	NULL
EKLF	NULL
interacts	NULL
with	NULL
a	NULL
positive-acting	NULL
cellular	NULL
factor	NULL
.	NULL

The	NULL
molecular	NULL
attributes	NULL
of	NULL
EKLF	NULL
,	NULL
in	NULL
the	NULL
context	NULL
of	NULL
its	NULL
biological	NULL
properties	NULL
,	NULL
led	NULL
us	NULL
to	NULL
consider	NULL
whether	NULL
EKLF	NULL
might	NULL
be	NULL
associating	NULL
with	NULL
molecules	NULL
that	NULL
alter	NULL
chromatin	NULL
structure	NULL
(	NULL
20	NULL
)	NULL
.	NULL

We	NULL
focused	NULL
on	NULL
the	NULL
particular	NULL
class	NULL
of	NULL
coactivators	NULL
that	NULL
exhibit	NULL
histone	NULL
acetyltransferase	NULL
(	NULL
HAT	NULL
)	NULL
activity	NULL
for	NULL
a	NULL
number	NULL
of	NULL
reasons	NULL
.	NULL

First	NULL
,	NULL
histone	NULL
acetylation	NULL
and	NULL
transcriptional	NULL
activation	NULL
are	NULL
intimately	NULL
associated	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
B-like	NULL
globin	NULL
locus	NULL
is	NULL
enriched	NULL
in	NULL
acetylated	NULL
histones	NULL
in	NULL
erythroid	NULL
cells	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
HAT	NULL
's	NULL
utilize	NULL
multiple	NULL
mechanisms	NULL
to	NULL
exert	NULL
a	NULL
range	NULL
of	NULL
effects	NULL
that	NULL
could	NULL
account	NULL
for	NULL
some	NULL
of	NULL
the	NULL
in	NULL
vivo	NULL
properties	NULL
exhibited	NULL
by	NULL
EKLF	NULL
.	NULL

For	NULL
example	NULL
,	NULL
they	NULL
can	NULL
serve	NULL
as	NULL
bridging	NULL
molecules	NULL
between	NULL
activators	NULL
and	NULL
the	NULL
basal	NULL
transcription	NULL
machinery	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
,	NULL
their	NULL
intrinsic	NULL
HAT	NULL
activity	NULL
can	NULL
disrupt	NULL
the	NULL
nucleosome	NULL
structure	NULL
and	NULL
allow	NULL
other	NULL
DNA-binding	NULL
proteins	NULL
greater	NULL
accessibility	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
they	NULL
can	NULL
alter	NULL
the	NULL
molecular	NULL
properties	NULL
of	NULL
at	NULL
least	NULL
one	NULL
nonhistone	NULL
transcription	NULL
factor	NULL
,	NULL
p53	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
EKLF	NULL
associates	NULL
with	NULL
HAT	NULL
's	NULL
and	NULL
that	NULL
this	NULL
interaction	NULL
leads	NULL
to	NULL
protein	NULL
acetylation	NULL
in	NULL
This	NULL
paper	NULL
was	NULL
submitted	NULL
directly	NULL
(	NULL
Track	NULL
II	NULL
)	NULL
to	NULL
the	NULL
Proceedings	NULL
office	NULL
.	NULL

Abbreviations	NULL
:	NULL
EKLF	NULL
,	NULL
erythroid	NULL
Kriippel-like	NULL
factor	NULL
;	NULL
CBP	NULL
,	NULL
CREB-binding	NULL
protein	NULL
;	NULL
P/CAF	NULL
,	NULL
p300/CBP	NULL
-associated	NULL
factor	NULL
;	NULL
HAT	NULL
,	NULL
histone	NULL
acetyltransferase	NULL
;	NULL
FAT	NULL
,	NULL
factor	NULL
acetyltransferase	NULL
;	NULL
TSA	NULL
,	NULL
trichostatin	NULL
A	NULL
;	NULL
HA	NULL
,	NULL
hemagglutinin	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
IP	NULL
,	NULL
immunopre-	NULL
cipitation	NULL
.	NULL

*To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
at	NULL
:	NULL
Mount	NULL
Sinai	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Brookdale	NULL
Center	NULL
for	NULL
Molecular	NULL
Biology	NULL
,	NULL
Box	NULL
1126	NULL
,	NULL
One	NULL
Gustave	NULL
L.	NULL
Levy	NULL
Place	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10029.	NULL
e-mail	NULL
:	NULL
jbicker	NULL
@	NULL
smtplink.mssm.edu	NULL
.	NULL

9856	NULL
Biochemistry	NULL
:	NULL
Zhang	NULL
and	NULL
Bicker	NULL
vitro	NULL
and	NULL
increased	NULL
activity	NULL
in	NULL
vivo	NULL
.	NULL

EKLF	NULL
thus	NULL
becomes	NULL
a	NULL
tissue-specific	NULL
example	NULL
of	NULL
the	NULL
factor	NULL
acetyltransferase	NULL
(	NULL
FAT	NULL
)	NULL
capability	NULL
of	NULL
p300	NULL
and	NULL
CBP	NULL
and	NULL
their	NULL
ability	NULL
to	NULL
modulate	NULL
transcription	NULL
factor	NULL
function	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture	NULL
.	NULL

K562	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
medium	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
.	NULL

COS7	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
DMEM	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
FBS	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
a	NULL
humidified	NULL
incubator	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
/95	NULL
%	NULL
air	NULL
atmo-sphere	NULL
.	NULL

Antibodies	NULL
.	NULL

Anti-CBP	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
raised	NULL
against	NULL
amino	NULL
acids	NULL
1736-2179	NULL
was	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
.	NULL

Anti-hemagglutinin	NULL
(	NULL
HA	NULL
)	NULL
monoclonal	NULL
antibody	NULL
was	NULL
purchased	NULL
from	NULL
the	NULL
Hybridoma	NULL
Core	NULL
Facility	NULL
at	NULL
Mt	NULL
.	NULL

Sinai	NULL
School	NULL
of	NULL
Medicine	NULL
.	NULL

Purified	NULL
anti-P/CAF	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Yoshihiro	NULL
Nakatani	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Anti-FLAG	NULL
MS	NULL
monoclonal	NULL
antibody	NULL
was	NULL
from	NULL
Kodak-IBI	NULL
.	NULL

4B9	NULL
and	NULL
6B3	NULL
are	NULL
two	NULL
mouse	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
EKLF	NULL
made	NULL
in	NULL
this	NULL
laboratory	NULL
.	NULL

We	NULL
used	NULL
a	NULL
rabbit	NULL
anti-peptide	NULL
polyclonal	NULL
antibody	NULL
(	NULL
29	NULL
)	NULL
or	NULL
the	NULL
4B9	NULL
antibody	NULL
for	NULL
Western	NULL
blot	NULL
analysis	NULL
and	NULL
the	NULL
6B3	NULL
antibody	NULL
for	NULL
immunoprecipitation	NULL
of	NULL
EKLE	NULL
.	NULL

Plasmid	NULL
Constructions	NULL
.	NULL

pSGS/EKLF	NULL
(	NULL
9	NULL
)	NULL
,	NULL
pCX/FLAG-P/	NULL
CAF	NULL
(	NULL
28	NULL
)	NULL
,	NULL
pCMVB-HA-P300	NULL
(	NULL
30	NULL
)	NULL
,	NULL
pRe/RSV/CBP	NULL
(	NULL
31	NULL
)	NULL
,	NULL
and	NULL
pHS2/B/luc	NULL
(	NULL
32	NULL
)	NULL
were	NULL
as	NULL
described	NULL
.	NULL

The	NULL
pCX	NULL
empty	NULL
vector	NULL
was	NULL
generated	NULL
from	NULL
EcoRI/Kprl-digested	NULL
pCX/FLAG-P/	NULL
CAF	NULL
.	NULL

pSG5/CBP	NULL
was	NULL
generated	NULL
by	NULL
insertion	NULL
of	NULL
the	NULL
BamHI	NULL
fragment	NULL
of	NULL
pRe/RSV/CBP	NULL
into	NULL
pSGS	NULL
.	NULL

GST-EKLF	NULL
constructs	NULL
(	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
)	NULL
were	NULL
as	NULL
described	NULL
(	NULL
9	NULL
,	NULL
18	NULL
)	NULL
except	NULL
as	NULL
follows	NULL
.	NULL

GST-EKLF	NULL
(	NULL
20-376	NULL
)	NULL
was	NULL
generated	NULL
by	NULL
PCR	NULL
of	NULL
pSGS5/EKLF	NULL
using	NULL
CAGCTGAGACT-3	NULL
'	NULL
and	NULL
5-CGCGGAATTCTCACTCA-GAGGTGACGCTTC-3	NULL
'	NULL
as	NULL
primers	NULL
,	NULL
digestion	NULL
with	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
,	NULL
and	NULL
insertion	NULL
into	NULL
pGEX-2TK	NULL
.	NULL

GST-EKLF	NULL
(	NULL
20-79	NULL
)	NULL
was	NULL
made	NULL
by	NULL
digestion	NULL
of	NULL
GST-EKLF	NULL
(	NULL
20-376	NULL
)	NULL
with	NULL
BspEI	NULL
and	NULL
EcoRI	NULL
and	NULL
ligation	NULL
of	NULL
the	NULL
filled-in	NULL
ends	NULL
.	NULL

GST-EKLF	NULL
(	NULL
A172-272	NULL
)	NULL
was	NULL
generated	NULL
by	NULL
digestion	NULL
of	NULL
GST-EKLF	NULL
(	NULL
20-376	NULL
)	NULL
with	NULL
Smal	NULL
,	NULL
removal	NULL
of	NULL
the	NULL
insert	NULL
,	NULL
and	NULL
self-ligation	NULL
.	NULL

GST-EKLF	NULL
(	NULL
272-376	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
digestion	NULL
of	NULL
GST-EKLF	NULL
(	NULL
20-376	NULL
)	NULL
with	NULL
Smal	NULL
followed	NULL
by	NULL
EcoRI	NULL
digestion	NULL
;	NULL
a	NULL
300-bp	NULL
fragment	NULL
of	NULL
EKLF	NULL
was	NULL
isolated	NULL
and	NULL
inserted	NULL
into	NULL
Smal	NULL
and	NULL
EcoRI	NULL
sites	NULL
of	NULL
pGEX-2TK	NULL
vector	NULL
.	NULL

GST-EKLF	NULL
(	NULL
20-124	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
insertion	NULL
of	NULL
the	NULL
BamHI	NULL
piece	NULL
from	NULL
pGAL/EKLF	NULL
(	NULL
20-124	NULL
)	NULL
(	NULL
19	NULL
)	NULL
into	NULL
pGEX-3X	NULL
.	NULL

Transfection	NULL
,	NULL
Immunoprecipitation	NULL
,	NULL
and	NULL
Western	NULL
Blot	NULL
Analysis	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
(	NULL
IP	NULL
)	NULL
,	NULL
60	NULL
%	NULL
confluent	NULL
COS7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
pSGS5-EKLF	NULL
,	NULL
pCX-pCAF	NULL
,	NULL
pRc/RSV/CBP	NULL
,	NULL
pCMV8/p300	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
10	NULL
ug	NULL
of	NULL
pSGS-EKLF	NULL
plus	NULL
either	NULL
10	NULL
ug	NULL
of	NULL
pCX-pCAF	NULL
,	NULL
pRe/RSV/CBP	NULL
,	NULL
or	NULL
pCMVB/p300	NULL
by	NULL
using	NULL
DMRIE	NULL
C	NULL
(	NULL
GIBCO/BRL	NULL
)	NULL
.	NULL

Thirty-six	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
cold	NULL
PBS	NULL
,	NULL
lysed	NULL
with	NULL
LSB	NULL
(	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.6/250	NULL
mM	NULL
NaCl/5	NULL
mM	NULL
EDTA/O0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
supplemented	NULL
with	NULL
protease	NULL
inhibitors	NULL
,	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Extracts	NULL
were	NULL
cleared	NULL
by	NULL
Microfuge	NULL
centrifugation	NULL
at	NULL
18,000	NULL
rpm	NULL
for	NULL
20	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

Supernatants	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
the	NULL
specific	NULL
antibodies	NULL
by	NULL
rocking	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
4°C	NULL
followed	NULL
by	NULL
addition	NULL
of	NULL
30	NULL
ul	NULL
of	NULL
a	NULL
50	NULL
%	NULL
slurry	NULL
of	NULL
protein	NULL
A	NULL
or	NULL
G	NULL
agarose	NULL
beads	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
further	NULL
incubation	NULL
for	NULL
1	NULL
hr	NULL
.	NULL

For	NULL
anti-CBP	NULL
,	NULL
anti-HA	NULL
,	NULL
anti-FLAG	NULL
MS	NULL
,	NULL
and	NULL
anti-pCAF	NULL
antibodies	NULL
,	NULL
protein	NULL
A	NULL
agarose	NULL
beads	NULL
were	NULL
used	NULL
;	NULL
for	NULL
6B3	NULL
anti-EKLF	NULL
antibody	NULL
,	NULL
protein	NULL
G	NULL
agarose	NULL
beads	NULL
were	NULL
used	NULL
.	NULL

Precipitated	NULL
complexes	NULL
were	NULL
pelleted	NULL
,	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
LSB	NULL
,	NULL
and	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
on	NULL
an	NULL
SDS/10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Proteins	NULL
were	NULL
electrotransferred	NULL
onto	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Protran	NULL
,	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
and	NULL
probed	NULL
with	NULL
the	NULL
appropriate	NULL
antibodies	NULL
.	NULL

Chemiluminescent	NULL
detection	NULL
(	NULL
Pierce	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
relied	NULL
on	NULL
horseradish	NULL
peroxidase	NULL
(	NULL
HRP	NULL
)	NULL
-conjugated	NULL
secondary	NULL
antibodies	NULL
.	NULL

IP-HAT	NULL
Assay	NULL
.	NULL

After	NULL
transfection	NULL
and	NULL
IP	NULL
as	NULL
above	NULL
,	NULL
an	NULL
IP-HAT	NULL
assay	NULL
was	NULL
conducted	NULL
as	NULL
described	NULL
(	NULL
33	NULL
)	NULL
with	NULL
slight	NULL
modification	NULL
.	NULL

Briefly	NULL
,	NULL
a	NULL
series	NULL
of	NULL
GST	NULL
and	NULL
GST-EKLF	NULL
fusion	NULL
proteins	NULL
were	NULL
purified	NULL
with	NULL
glutathione	NULL
beads	NULL
from	NULL
BL21	NULL
expression	NULL
bacterial	NULL
lysates	NULL
after	NULL
a	NULL
2-hr	NULL
induction	NULL
with	NULL
1	NULL
mM	NULL
isopropyl	NULL
B-D-thiogalactoside	NULL
(	NULL
IPTG	NULL
)	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
purified	NULL
GST-EKLF	NULL
fusions	NULL
was	NULL
added	NULL
to	NULL
each	NULL
tube	NULL
of	NULL
IP	NULL
complex	NULL
together	NULL
with	NULL
1	NULL
wl	NULL
of	NULL
0.25	NULL
mCi/ml	NULL
(	NULL
5.1	NULL
Ci/mmol	NULL
;	NULL
Amersham	NULL
;	NULL
1	NULL
Ci	NULL
=	NULL
37	NULL
GBq	NULL
)	NULL
.	NULL

Mixtures	NULL
were	NULL
incubated	NULL
at	NULL
30°C	NULL
for	NULL
1	NULL
hr	NULL
and	NULL
electrophoresed	NULL
in	NULL
an	NULL
SDS/10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
then	NULL
fixed	NULL
in	NULL
30	NULL
%	NULL
methanol/	NULL
10	NULL
%	NULL
acetic	NULL
acid/60	NULL
%	NULL
water	NULL
(	NULL
vol/vol	NULL
)	NULL
for	NULL
40	NULL
min	NULL
,	NULL
immersed	NULL
into	NULL
EN°HANCE	NULL
solution	NULL
(	NULL
DuPont	NULL
)	NULL
for	NULL
45	NULL
min	NULL
,	NULL
and	NULL
precipitated	NULL
for	NULL
another	NULL
30	NULL
min	NULL
in	NULL
water	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
then	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
for	NULL
3	NULL
days	NULL
at	NULL
-80°C	NULL
.	NULL

The	NULL
same	NULL
samples	NULL
were	NULL
also	NULL
electrophoresed	NULL
on	NULL
a	NULL
separate	NULL
SDS/10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
stained	NULL
.	NULL

In	NULL
Vivo	NULL
Labeling	NULL
of	NULL
EKLF	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
pSGS5/EKLF	NULL
or	NULL
pSGS5	NULL
was	NULL
transfected	NULL
as	NULL
described	NULL
above	NULL
into	NULL
one	NULL
10-cm	NULL
dish	NULL
of	NULL
COS7	NULL
cells	NULL
per	NULL
test	NULL
.	NULL

After	NULL
30	NULL
hr	NULL
,	NULL
the	NULL
DMEM	NULL
was	NULL
replaced	NULL
with	NULL
DMEM	NULL
containing	NULL
1	NULL
mCi/ml	NULL
sodium	NULL
[	NULL
*HJacetate	NULL
(	NULL
ICN	NULL
)	NULL
and	NULL
2	NULL
wM	NULL
trichostatin	NULL
A	NULL
(	NULL
TSA	NULL
;	NULL
Wako	NULL
)	NULL
for	NULL
1	NULL
hr	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
and	NULL
processed	NULL
as	NULL
described	NULL
above	NULL
,	NULL
using	NULL
the	NULL
6B3	NULL
monoclonal	NULL
antibody	NULL
.	NULL

One	NULL
group	NULL
of	NULL
transfections	NULL
were	NULL
labeled	NULL
,	NULL
while	NULL
a	NULL
parallel	NULL
group	NULL
was	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Cotransfections	NULL
and	NULL
Luciferase	NULL
and	NULL
Growth	NULL
Hormone	NULL
As-says	NULL
.	NULL

K562	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
desired	NULL
plasmids	NULL
by	NULL
using	NULL
DMRIE	NULL
C	NULL
(	NULL
GIBCO/BRL	NULL
)	NULL
.	NULL

In	NULL
short	NULL
,	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
added	NULL
to	NULL
a	NULL
1-ml	NULL
mixture	NULL
of	NULL
DMRIE	NULL
C	NULL
reagent	NULL
and	NULL
DNA	NULL
in	NULL
35-mm	NULL
dishes	NULL
.	NULL

After	NULL
5	NULL
hr	NULL
,	NULL
2	NULL
ml	NULL
of	NULL
RPMI	NULL
medium	NULL
1640	NULL
containing	NULL
20	NULL
%	NULL
FBS	NULL
was	NULL
added	NULL
into	NULL
the	NULL
dish	NULL
.	NULL

TSA	NULL
(	NULL
2	NULL
uM	NULL
)	NULL
was	NULL
added	NULL
as	NULL
appropriate	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
normalized	NULL
by	NULL
cotransfecting	NULL
pXGHS	NULL
growth	NULL
hormone	NULL
plasmid	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

Thirty-six	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
the	NULL
luciferase	NULL
assay	NULL
(	NULL
Promega	NULL
kit	NULL
)	NULL
,	NULL
using	NULL
equivalent	NULL
amounts	NULL
of	NULL
extracted	NULL
protein	NULL
;	NULL
media	NULL
supernatants	NULL
were	NULL
used	NULL
for	NULL
the	NULL
growth	NULL
hormone	NULL
assay	NULL
(	NULL
Nichols	NULL
Institute	NULL
)	NULL
.	NULL

Luciferase	NULL
levels	NULL
are	NULL
plotted	NULL
after	NULL
normalization	NULL
to	NULL
cotransfected	NULL
growth	NULL
hormone	NULL
levels	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
repeated	NULL
three	NULL
times	NULL
in	NULL
duplicate	NULL
.	NULL

RESULTS	NULL
EKLF	NULL
Associates	NULL
with	NULL
CBP	NULL
,	NULL
p300	NULL
,	NULL
and	NULL
P/CAF	NULL
in	NULL
Vivo	NULL
.	NULL

We	NULL
began	NULL
our	NULL
studies	NULL
by	NULL
determining	NULL
whether	NULL
EKLF	NULL
could	NULL
interact	NULL
in	NULL
vivo	NULL
with	NULL
three	NULL
proteins	NULL
that	NULL
contain	NULL
HAT	NULL
activity	NULL
:	NULL
CBP	NULL
,	NULL
p300	NULL
,	NULL
and	NULL
P/CAF	NULL
.	NULL

Constructs	NULL
that	NULL
drive	NULL
expression	NULL
of	NULL
each	NULL
of	NULL
these	NULL
(	NULL
pRSV-CBP	NULL
,	NULL
pCMVB/HA-p300	NULL
,	NULL
or	NULL
pCX/FLAG-P/	NULL
CAF	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
EKLF	NULL
expression	NULL
vector	NULL
(	NULL
pSGS-EKLF	NULL
)	NULL
into	NULL
COS7	NULL
cells	NULL
.	NULL

After	NULL
36	NULL
hr	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-CBP	NULL
,	NULL
anti-HA	NULL
(	NULL
for	NULL
p300	NULL
)	NULL
,	NULL
or	NULL
anti-P/CAF	NULL
antibodies	NULL
,	NULL
and	NULL
the	NULL
material	NULL
was	NULL
monitored	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
EKLF	NULL
after	NULL
electrophoresis	NULL
,	NULL
transfer	NULL
,	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
the	NULL
anti-EKLF	NULL
(	NULL
4B9	NULL
)	NULL
antibody	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
antibodies	NULL
to	NULL
each	NULL
of	NULL
the	NULL
HAT	NULL
proteins	NULL
are	NULL
able	NULL
to	NULL
coprecipitate	NULL
EKLF	NULL
from	NULL
extracts	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
)	NULL
.	NULL

This	NULL
result	NULL
requires	NULL
cotransfection	NULL
of	NULL
HAT	NULL
protein	NULL
and	NULL
EKLF	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

This	NULL
interaction	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
reverse	NULL
experiment	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
immunoprecipitation	NULL
with	NULL
anti-EKLF	NULL
(	NULL
6B3	NULL
)	NULL
antibody	NULL
followed	NULL
by	NULL
blotting	NULL
with	NULL
anti-HA	NULL
also	NULL
reveals	NULL
the	NULL
p300/EKLF	NULL
interaction	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
CBP	NULL
,	NULL
p300	NULL
,	NULL
and	NULL
P/CAF	NULL
can	NULL
all	NULL
interact	NULL
with	NULL
EKLF	NULL
in	NULL
vivo	NULL
.	NULL

CBP	NULL
and	NULL
p300	NULL
,	NULL
but	NULL
Not	NULL
P/CAF	NULL
,	NULL
Acetylate	NULL
EKLF	NULL
in	NULL
Vitro	NULL
.	NULL

Although	NULL
CBP	NULL
and	NULL
p300	NULL
were	NULL
originally	NULL
isolated	NULL
as	NULL
coactivators	NULL
that	NULL
act	NULL
as	NULL
bridging	NULL
proteins	NULL
between	NULL
upstream	NULL
activators	NULL
and	NULL
the	NULL
basal	NULL
transcription	NULL
apparatus	NULL
(	NULL
34	NULL
)	NULL
,	NULL
the	NULL
recent	NULL
demonstration	NULL
of	NULL
their	NULL
FAT	NULL
activity	NULL
on	NULL
p53	NULL
(	NULL
27	NULL
)	NULL
and	NULL
Biochemistry	NULL
:	NULL
Zhang	NULL
and	NULL
Bicker	NULL
TFIIER	NULL
and	NULL
TFIIF	NULL
(	NULL
35	NULL
)	NULL
prompted	NULL
us	NULL
to	NULL
determine	NULL
if	NULL
EKLF	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
acetylation	NULL
by	NULL
CBP	NULL
,	NULL
p300	NULL
,	NULL
or	NULL
P/CAF	NULL
.	NULL

We	NULL
performed	NULL
these	NULL
experiments	NULL
in	NULL
vitro	NULL
by	NULL
using	NULL
purified	NULL
recom-binant	NULL
GST-EKLF	NULL
fusion	NULL
proteins	NULL
as	NULL
substrates	NULL
for	NULL
immunoprecipitated	NULL
HAT	NULL
molecules	NULL
derived	NULL
from	NULL
transfected	NULL
COS7	NULL
cells	NULL
.	NULL

Fig	NULL
.	NULL

24	NULL
demonstrates	NULL
that	NULL
CBP	NULL
and	NULL
p300	NULL
are	NULL
both	NULL
able	NULL
to	NULL
acetylate	NULL
a	NULL
GST-EKLF	NULL
(	NULL
76-376	NULL
)	NULL
construct	NULL
in	NULL
vitro	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
5	NULL
)	NULL
;	NULL
however	NULL
,	NULL
P/CAF	NULL
is	NULL
not	NULL
able	NULL
to	NULL
do	NULL
so	NULL
(	NULL
lanes	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Autoacetylated	NULL
CBP	NULL
,	NULL
p300	NULL
,	NULL
and	NULL
P/CAF	NULL
bands	NULL
indicate	NULL
that	NULL
the	NULL
HAT	NULL
molecule	NULL
in	NULL
each	NULL
immunoprecipitated	NULL
complex	NULL
is	NULL
enzy-matically	NULL
active	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
IP	NULL
of	NULL
nontransfected	NULL
COS7	NULL
cells	NULL
did	NULL
not	NULL
yield	NULL
any	NULL
acetylated	NULL
EKLF	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
8	NULL
)	NULL
,	NULL
and	NULL
EKLF	NULL
did	NULL
not	NULL
autoacetylate	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
EKLF	NULL
is	NULL
specifically	NULL
acetylated	NULL
only	NULL
by	NULL
p300	NULL
and	NULL
CBP	NULL
,	NULL
and	NULL
not	NULL
by	NULL
P/CAF	NULL
.	NULL

We	NULL
used	NULL
the	NULL
robust	NULL
signal	NULL
generated	NULL
by	NULL
CBP	NULL
acetylation	NULL
in	NULL
vitro	NULL
to	NULL
map	NULL
potential	NULL
target	NULL
sites	NULL
within	NULL
EKLF	NULL
.	NULL

A	NULL
series	NULL
of	NULL
GST	NULL
fusion	NULL
proteins	NULL
harboring	NULL
different	NULL
EKLF	NULL
deletions	NULL
were	NULL
used	NULL
as	NULL
substrates	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
EKLF	NULL
trans-activation	NULL
region	NULL
contains	NULL
five	NULL
lysines	NULL
that	NULL
are	NULL
conserved	NULL
in	NULL
the	NULL
human	NULL
and	NULL
the	NULL
murine	NULL
orthologues	NULL
(	NULL
9	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
substrate	NULL
suitability	NULL
of	NULL
the	NULL
EKLF	NULL
fragments	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
indicates	NULL
that	NULL
Lys-47	NULL
and	NULL
Lys-71	NULL
are	NULL
not	NULL
used	NULL
,	NULL
but	NULL
that	NULL
Lys-279	NULL
and	NULL
Lys-288	NULL
are	NULL
likely	NULL
target	NULL
sites	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
are	NULL
located	NULL
within	NULL
the	NULL
EKLF	NULL
inhibitory	NULL
domain	NULL
immediately	NULL
on	NULL
the	NULL
amino	NULL
side	NULL
of	NULL
the	NULL
zinc	NULL
fingers	NULL
.	NULL

EKLF	NULL
Is	NULL
an	NULL
Acetylated	NULL
Protein	NULL
in	NULL
Vivo	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
whether	NULL
EKLF	NULL
is	NULL
acetylated	NULL
in	NULL
vivo	NULL
by	NULL
immunoprecipitating	NULL
EKLE	NULL
#	NULL
--	NULL
+0	NULL
+4	NULL
--	NULL
+	NULL
#	NULL
+	NULL
-	NULL
+	NULL
.	NULL

|	NULL
PICAF	NULL
=-	NULL
4	NULL
+	NULL
#	NULL
TRANSFECT	NULL
:	NULL
HA-p300	NULL
s	NULL
$	NULL
%	NULL
CBP	NULL
:	NULL
*	NULL
IMMUNOPRECIPITATE	NULL
:	NULL
\	NULL
--	NULL
P/CAF	NULL
--	NULL
--	NULL
HA-	NULL
__	NULL
--	NULL
CBP	NULL
--	NULL
a	NULL
``	NULL
*~	NULL
=	NULL
>	NULL
me	NULL
#	NULL
*	NULL
=	NULL
--	NULL
@	NULL
-EKLF	NULL
EKLF	NULL
-	NULL
#	NULL
te	NULL
<	NULL
p	NULL
1	NULL
2	NULL
3	NULL
400506	NULL
7	NULL
8	NULL
9	NULL
0	NULL
#	NULL
--	NULL
+	NULL
TRANSFECT	NULL
:	NULL
HA-p3o0	NULL
|	NULL
=-	NULL
4	NULL
4	NULL
IMMUNOPRECIPITATE	NULL
:	NULL
--	NULL
EKLF	NULL
--	NULL
+	NULL
>	NULL
4	NULL
<	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Tests	NULL
of	NULL
EKLF	NULL
interaction	NULL
with	NULL
CBP	NULL
,	NULL
p300	NULL
,	NULL
and	NULL
P/CAF	NULL
in	NULL
vivo	NULL
.	NULL

Combinations	NULL
of	NULL
EKLF	NULL
and	NULL
HAT	NULL
coactivator	NULL
expression	NULL
plasmids	NULL
(	NULL
10	NULL
pg	NULL
each	NULL
)	NULL
as	NULL
indicated	NULL
were	NULL
transfected	NULL
into	NULL
COS7	NULL
cells	NULL
and	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
anti-CBP	NULL
,	NULL
anti-HA	NULL
,	NULL
anti-P/CAF	NULL
,	NULL
or	NULL
anti-EKLF	NULL
antibodies	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Immunoprecipitated	NULL
complexes	NULL
were	NULL
resolved	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
anti-EKLF	NULL
monoclonal	NULL
antibody	NULL
4B9	NULL
.	NULL

Location	NULL
of	NULL
co-electrophoresed	NULL
EKLF	NULL
in	NULL
each	NULL
gel	NULL
is	NULL
shown	NULL
.	NULL

Asterisks	NULL
indicate	NULL
nonspecific	NULL
(	NULL
Ig	NULL
heavy	NULL
chain	NULL
)	NULL
signals	NULL
from	NULL
the	NULL
immunoprecipitating	NULL
antibodies	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Immunoprecipitated	NULL
complexes	NULL
were	NULL
resolved	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
anti-HA	NULL
monoclonal	NULL
antibody	NULL
for	NULL
detection	NULL
of	NULL
p300	NULL
.	NULL

Location	NULL
of	NULL
co-electrophoresed	NULL
HA-p300	NULL
is	NULL
shown	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
9857	NULL
EKLF	NULL
from	NULL
transfected	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
labeled	NULL
for	NULL
1	NULL
hr	NULL
with	NULL
sodium	NULL
[	NULL
*HJacetate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
histone	NULL
deacety-lase	NULL
inhibitor	NULL
(	NULL
TSA	NULL
)	NULL
prior	NULL
to	NULL
lysis	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
of	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
immunoprecipitated	NULL
samples	NULL
indicates	NULL
that	NULL
EKLF	NULL
is	NULL
recovered	NULL
from	NULL
EKLF-transfected	NULL
but	NULL
not	NULL
empty	NULL
vector-transfected	NULL
cells	NULL
,	NULL
and	NULL
autoradiography	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
indicates	NULL
that	NULL
the	NULL
immunoprecipitated	NULL
EKLF	NULL
is	NULL
the	NULL
only	NULL
labeled	NULL
protein	NULL
in	NULL
either	NULL
extract	NULL
.	NULL

These	NULL
data	NULL
directly	NULL
demonstrate	NULL
that	NULL
EKLF	NULL
is	NULL
an	NULL
acetylated	NULL
transcription	NULL
factor	NULL
in	NULL
vivo	NULL
.	NULL

CBP	NULL
and	NULL
p300	NULL
,	NULL
but	NULL
Not	NULL
P/CAF	NULL
,	NULL
Enhance	NULL
EKLF	NULL
Transactivation	NULL
in	NULL
Erythroid	NULL
Cells	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
functional	NULL
consequence	NULL
of	NULL
physical	NULL
interaction	NULL
and	NULL
acetylation	NULL
of	NULL
EKLF	NULL
by	NULL
HAT	NULL
molecules	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
effect	NULL
of	NULL
HAT	NULL
proteins	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
EKLF	NULL
to	NULL
transactivate	NULL
the	NULL
B-globin	NULL
promoter	NULL
,	NULL
which	NULL
is	NULL
its	NULL
normal	NULL
activation	NULL
target	NULL
(	NULL
9	NULL
)	NULL
.	NULL

For	NULL
this	NULL
experiment	NULL
we	NULL
A	NULL
Juara	NULL
+	NULL
4+	NULL
--	NULL
TRANSFECT	NULL
:	NULL
E®Cat	NULL
p	NULL
Se	NULL
|	NULL
me	NULL
IMMUNOPRECIPITATE	NULL
:	NULL
-	NULL
--	NULL
HA	NULL
--	NULL
-CBP-	NULL
--	NULL
FMS	NULL
--	NULL
«	NULL
«	NULL
rors	NULL
bue	NULL
bound	NULL
--	NULL
S=	NULL
<	NULL
P/CAF	NULL
GST-EKLE-	NULL
»	NULL
«	NULL
--	NULL
-	NULL
»	NULL
__	NULL
@	NULL
»	NULL
L_	NULL
GST-EKLF	NULL
-	NULL
»	NULL
«	NULL
«	NULL
-	NULL
me	NULL
t	NULL
»	NULL
tur	NULL
car	NULL
us	NULL
use	NULL
ust	NULL
*~	NULL
Senu	NULL
thee	NULL
waw	NULL
guise	NULL
guo	NULL
1	NULL
2003	NULL
40	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
47	NULL
74	NULL
17	NULL
29	NULL
rss	NULL
B	NULL
mee	NULL
ore	NULL
Sve	NULL
oct	NULL
amg	NULL
<	NULL
CBP	NULL
#	NULL
7	NULL
~-	NULL
caer	NULL
nese	NULL
Sues	NULL
*	NULL
i—HIH	NULL
'	NULL
Ts	NULL
r	NULL
*	NULL
,	NULL
'	NULL
_-	NULL
``	NULL
%	NULL
seee	NULL
__	NULL
ut	NULL
MURINE	NULL
|_	NULL
HUMAN	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
44	NULL
-	NULL
DFIKNWR	NULL
-	NULL
DFIKWWR	NULL
71	NULL
VSIKSED	NULL
|	NULL
LeWsED	NULL
174	NULL
LAFAQP	NULL
|	NULL
PEALA	NULL
276	NULL
APMRSR	NULL
AP	NULL
&	NULL
RCR	NULL
285	NULL
LARRQA	NULL
|	NULL
WARRQA	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Tests	NULL
of	NULL
EKLF	NULL
acetylation	NULL
by	NULL
CBP	NULL
,	NULL
p300	NULL
,	NULL
and	NULL
P/CAF	NULL
in	NULL
vitro	NULL
.	NULL

(	NULL
A	NULL
)	NULL
COS7	NULL
cells	NULL
were	NULL
transfected	NULL
and	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
indicated	NULL
antibodies	NULL
.	NULL

IP-HAT	NULL
assays	NULL
utilized	NULL
5	NULL
ug	NULL
of	NULL
GST-EKLF	NULL
(	NULL
76-376	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
electrophoresed	NULL
and	NULL
the	NULL
dried	NULL
gel	NULL
was	NULL
exposed	NULL
in	NULL
autoradiography	NULL
(	NULL
Upper	NULL
)	NULL
.	NULL

GST-EKLF	NULL
(	NULL
76-376	NULL
)	NULL
alone	NULL
was	NULL
tested	NULL
for	NULL
autoacetylation	NULL
in	NULL
lane	NULL
9	NULL
.	NULL

Locations	NULL
of	NULL
p300/CBP	NULL
,	NULL
P/CAF	NULL
,	NULL
and	NULL
GST-EKLF	NULL
are	NULL
indicated	NULL
.	NULL

Protein	NULL
samples	NULL
were	NULL
also	NULL
stained	NULL
to	NULL
show	NULL
that	NULL
equivalent	NULL
amounts	NULL
were	NULL
used	NULL
(	NULL
Lower	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Endogenous	NULL
CBP	NULL
from	NULL
COS7	NULL
cells	NULL
was	NULL
immunoprecipitated	NULL
,	NULL
and	NULL
IP-HAT	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
various	NULL
GST-EKLF	NULL
fusion	NULL
proteins	NULL
as	NULL
diagrammed	NULL
on	NULL
the	NULL
Right	NULL
,	NULL
which	NULL
also	NULL
shows	NULL
the	NULL
locations	NULL
and	NULL
sequences	NULL
of	NULL
lysines	NULL
conserved	NULL
between	NULL
mouse	NULL
and	NULL
human	NULL
EKLF	NULL
[	NULL
amino	NULL
acid	NULL
residues	NULL
47	NULL
,	NULL
74	NULL
,	NULL
177	NULL
,	NULL
279	NULL
,	NULL
288	NULL
;	NULL
mouse	NULL
numbering	NULL
is	NULL
based	NULL
on	NULL
initiator	NULL
methionine	NULL
being	NULL
residue	NULL
19	NULL
(	NULL
9	NULL
)	NULL
]	NULL
.	NULL

Proteins	NULL
were	NULL
resolved	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
(	NULL
Upper	NULL
Leff	NULL
)	NULL
or	NULL
stained	NULL
for	NULL
protein	NULL
(	NULL
Lower	NULL
Left	NULL
)	NULL
.	NULL

Asterisks	NULL
show	NULL
the	NULL
location	NULL
of	NULL
nondegraded	NULL
GST-EKLF	NULL
fusion	NULL
proteins	NULL
.	NULL

Molecular	NULL
mass	NULL
markers	NULL
(	NULL
on	NULL
the	NULL
left	NULL
)	NULL
are	NULL
70	NULL
,	NULL
55	NULL
,	NULL
33	NULL
,	NULL
25	NULL
,	NULL
and	NULL
15	NULL
kDa	NULL
(	NULL
top	NULL
to	NULL
bottom	NULL
)	NULL
.	NULL

9858	NULL
Biochemistry	NULL
:	NULL
Zhang	NULL
and	NULL
Bicker	NULL
G5/	NULL
SGS/	NULL
pS	NULL
pSG5	NULL
Eu	NULL
;	NULL
pSCS5	NULL
EKLF	NULL
e	NULL
wwe	NULL
EKLF	NULL
-	NULL
»	NULL
-~	NULL
1	NULL
2	NULL
3	NULL
4	NULL
WESTERN	NULL
BLOT	NULL
AUTORADIOGRAPH	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Status	NULL
of	NULL
EKLF	NULL
acetylation	NULL
in	NULL
vivo	NULL
.	NULL

COS7	NULL
cells	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
pSGS	NULL
or	NULL
pSGS/EKLEF	NULL
as	NULL
indicated	NULL
were	NULL
labeled	NULL
with	NULL
sodium	NULL
[	NULL
*HJacetate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TSA	NULL
and	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-EKLF	NULL
monoclonal	NULL
antibody	NULL
6B3	NULL
.	NULL

Immunoprecipitated	NULL
samples	NULL
were	NULL
resolved	NULL
on	NULL
SDS/PAGE	NULL
and	NULL
blotted	NULL
and	NULL
probed	NULL
with	NULL
anti-EKLF	NULL
(	NULL
Leff	NULL
)	NULL
or	NULL
processed	NULL
and	NULL
exposed	NULL
in	NULL
autoradiography	NULL
(	NULL
Right	NULL
)	NULL
.	NULL

Asterisk	NULL
indicates	NULL
a	NULL
nonspecific	NULL
signal	NULL
from	NULL
the	NULL
immunoprecipitating	NULL
antibody	NULL
.	NULL

Locations	NULL
of	NULL
molecular	NULL
mass	NULL
markers	NULL
(	NULL
70	NULL
,	NULL
50	NULL
,	NULL
and	NULL
33	NULL
kDa	NULL
,	NULL
top	NULL
to	NULL
bottom	NULL
)	NULL
and	NULL
EKLF	NULL
are	NULL
shown	NULL
.	NULL

used	NULL
K562	NULL
,	NULL
which	NULL
is	NULL
a	NULL
human	NULL
erythroleukemic	NULL
cell	NULL
line	NULL
that	NULL
does	NULL
not	NULL
express	NULL
EKLF	NULL
(	NULL
36	NULL
)	NULL
.	NULL

K562	NULL
cells	NULL
express	NULL
the	NULL
fetal	NULL
y-globin	NULL
gene	NULL
but	NULL
not	NULL
the	NULL
endogenous	NULL
or	NULL
a	NULL
transfected	NULL
adult	NULL
-globin	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
cotransfection	NULL
of	NULL
EKLF	NULL
with	NULL
a	NULL
B-globin	NULL
gene	NULL
reporter	NULL
construct	NULL
switches	NULL
on	NULL
its	NULL
expression	NULL
(	NULL
12	NULL
)	NULL
.	NULL

We	NULL
reasoned	NULL
that	NULL
use	NULL
of	NULL
the	NULL
natural	NULL
B-globin	NULL
promoter	NULL
in	NULL
an	NULL
erythroid	NULL
cell	NULL
would	NULL
provide	NULL
a	NULL
stringent	NULL
test	NULL
for	NULL
any	NULL
effect	NULL
of	NULL
HAT	NULL
proteins	NULL
upon	NULL
EKLF	NULL
trans-activation	NULL
.	NULL

Cotransfection	NULL
of	NULL
pSGS-EKLF	NULL
and	NULL
the	NULL
pHS2/B/luc	NULL
reporter	NULL
were	NULL
performed	NULL
with	NULL
pSGS5-CBP	NULL
,	NULL
pCMVB/HA-p300	NULL
,	NULL
pCX/FLAG-P/CAF	NULL
,	NULL
or	NULL
their	NULL
corresponding	NULL
empty	NULL
vectors	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
indicate	NULL
that	NULL
EKLF	NULL
activates	NULL
the	NULL
B-globin	NULL
reporter	NULL
as	NULL
expected	NULL
,	NULL
and	NULL
that	NULL
CBP	NULL
and	NULL
p300	NULL
can	NULL
further	NULL
boost	NULL
this	NULL
high	NULL
level	NULL
of	NULL
activity	NULL
an	NULL
additional	NULL
2-	NULL
to	NULL
3-fold	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A-C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
P/CAF	NULL
significantly	NULL
inhibits	NULL
EKLF	NULL
transactivation	NULL
by	NULL
6-fold	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

Trans-activation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TSA	NULL
can	NULL
further	NULL
potentiate	NULL
the	NULL
effects	NULL
of	NULL
CBP	NULL
and	NULL
p300	NULL
,	NULL
but	NULL
not	NULL
P/CAF	NULL
,	NULL
activation	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
functional	NULL
consequence	NULL
of	NULL
interaction	NULL
between	NULL
EKLF	NULL
and	NULL
CBP	NULL
or	NULL
p300	NULL
is	NULL
to	NULL
positively	NULL
affect	NULL
its	NULL
transactivational	NULL
ability	NULL
,	NULL
maybe	NULL
in	NULL
part	NULL
as	NULL
a	NULL
result	NULL
of	NULL
EKLF	NULL
acetylation	NULL
.	NULL

DISCUSSION	NULL
EKLF	NULL
is	NULL
an	NULL
erythroid	NULL
transcription	NULL
factor	NULL
that	NULL
plays	NULL
direct	NULL
or	NULL
indirect	NULL
roles	NULL
in	NULL
activation	NULL
of	NULL
B-globin	NULL
transcription	NULL
(	NULL
12-14	NULL
)	NULL
,	NULL
consolidation	NULL
of	NULL
the	NULL
switch	NULL
from	NULL
y-	NULL
to	NULL
B-globin	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
,	NULL
and	NULL
generation	NULL
of	NULL
an	NULL
intact	NULL
chromatin	NULL
structure	NULL
at	NULL
the	NULL
B-like	NULL
globin	NULL
locus	NULL
(	NULL
17	NULL
)	NULL
.	NULL

As	NULL
EKLF	NULL
interacts	NULL
with	NULL
other	NULL
proteins	NULL
in	NULL
vivo	NULL
(	NULL
19	NULL
)	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
HAT	NULL
's	NULL
might	NULL
play	NULL
a	NULL
role	NULL
in	NULL
helping	NULL
coordinate	NULL
EKLEF	NULL
's	NULL
diverse	NULL
effects	NULL
on	NULL
expression	NULL
.	NULL

Specificity	NULL
of	NULL
EKLF-HAT	NULL
Interaction	NULL
.	NULL

There	NULL
are	NULL
two	NULL
levels	NULL
of	NULL
target	NULL
specificity	NULL
by	NULL
HATs	NULL
upon	NULL
EKLF	NULL
.	NULL

First	NULL
,	NULL
not	NULL
all	NULL
potential	NULL
lysines	NULL
are	NULL
acetylated	NULL
in	NULL
EKLF	NULL
.	NULL

Second	NULL
,	NULL
not	NULL
all	NULL
HAT	NULL
's	NULL
utilize	NULL
EKLF	NULL
as	NULL
substrate	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
P/CAF	NULL
to	NULL
acetylate	NULL
EKLF	NULL
is	NULL
not	NULL
due	NULL
to	NULL
limitation	NULL
of	NULL
its	NULL
substrate	NULL
specificity	NULL
to	NULL
histones	NULL
,	NULL
as	NULL
it	NULL
can	NULL
acetylate	NULL
itself	NULL
,	NULL
TFIIE	NULL
$	NULL
,	NULL
and	NULL
TFIIF	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Although	NULL
P/CAF	NULL
was	NULL
originally	NULL
isolated	NULL
by	NULL
its	NULL
interaction	NULL
with	NULL
CBP	NULL
(	NULL
28	NULL
)	NULL
,	NULL
these	NULL
two	NULL
molecules	NULL
do	NULL
not	NULL
always	NULL
play	NULL
the	NULL
same	NULL
role	NULL
together	NULL
,	NULL
for	NULL
example	NULL
during	NULL
muscle	NULL
cell	NULL
differentiation	NULL
(	NULL
37	NULL
)	NULL
and	NULL
in	NULL
RAR-	NULL
,	NULL
STAT1-	NULL
,	NULL
or	NULL
CREB-dependent	NULL
transcription	NULL
(	NULL
38	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
case	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
P/CAF	NULL
to	NULL
interact	NULL
with	NULL
,	NULL
yet	NULL
not	NULL
acetylate	NULL
,	NULL
EKLF	NULL
is	NULL
not	NULL
a	NULL
passive	NULL
event	NULL
,	NULL
but	NULL
instead	NULL
leads	NULL
to	NULL
inhibition	NULL
of	NULL
EKLF	NULL
trans-activation	NULL
.	NULL

This	NULL
may	NULL
be	NULL
functionally	NULL
significant	NULL
,	NULL
as	NULL
P/CAF	NULL
levels	NULL
are	NULL
altered	NULL
in	NULL
terminally	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
ba	NULL
B	NULL
40	NULL
6	NULL
&	NULL
8	NULL
w	NULL
1s	NULL
a	NULL
&	NULL
a	NULL
G	NULL
1o	NULL
NORMALIZED	NULL
LUCIFERASE	NULL
ACTIVITY	NULL
NORMALIZED	NULL
LUCIFERASE	NULL
ACTIVITY	NULL
0	NULL
0	NULL
pSGs	NULL
60	NULL
10	NULL
5	NULL
pSG	NULL
&	NULL
/EKLE	NULL
10	NULL
df	NULL
f	NULL
10	NULL
10	NULL
1	NULL
pSGS/EKLE	NULL
1	NULL
pSG5/CBRP	NULL
-	NULL
2s	NULL
50	NULL
40	NULL
500	NULL
10	NULL
pSGS/CBP	NULL
5	NULL
5005	NULL
pSGs	NULL
10	NULL
75	NULL
5	NULL
§00=	NULL
oi	NULL
TSA	NULL
|	NULL
-	NULL
-	NULL
+	NULL
40	NULL
®	NULL
&	NULL
t	NULL
E	NULL
so	NULL
9	NULL
§	NULL
tu	NULL
<	NULL
t	NULL
tu	NULL
<	NULL
0	NULL
Pa	NULL
4	NULL
Bi-	NULL
20	NULL
5	NULL
10	NULL
6	NULL
re	NULL
5	NULL
o	NULL
5	NULL
2	NULL
a	NULL
i	NULL
a	NULL
BN	NULL
10	NULL
8	NULL
5	NULL
8	NULL
a	NULL
$	NULL
a	NULL
f	NULL
=	NULL
6	NULL
&	NULL
g	NULL
9	NULL
0	NULL
4	NULL
0	NULL
psGs	NULL
1	NULL
0	NULL
1	NULL
psGs	NULL
1	NULL
1	NULL
pemv	NULL
os	NULL
5	NULL
pox	NULL
s	NULL
5	NULL
pSGSIEKLE	NULL
10	NULL
f	NULL
i	NULL
pSGSEKLE	NULL
Po	NULL
fo	NULL
O1	NULL
pCMV/p300	NULL
5	NULL
5005	NULL
pCUP/CaAF	NULL
5	NULL
5005	NULL
TSA	NULL
<	NULL
k	NULL
e	NULL
e	NULL
%	NULL
TSA	NULL
A	NULL
k	NULL
e	NULL
m	NULL
+	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Analyses	NULL
of	NULL
EKLF	NULL
transactivation	NULL
of	NULL
the	NULL
B-globin	NULL
promoter	NULL
.	NULL

K562	NULL
erythroleukemic	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
HS2/B/luc	NULL
reporter	NULL
and	NULL
the	NULL
indicated	NULL
amounts	NULL
(	NULL
ug	NULL
)	NULL
of	NULL
expression	NULL
or	NULL
vector	NULL
plasmids	NULL
,	NULL
and	NULL
extracts	NULL
were	NULL
processed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

TSA	NULL
was	NULL
added	NULL
where	NULL
indicated	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
2	NULL
wM	NULL
at	NULL
the	NULL
time	NULL
of	NULL
transfection	NULL
.	NULL

Multiple	NULL
experiments	NULL
were	NULL
averaged	NULL
after	NULL
normalization	NULL
of	NULL
luciferase	NULL
activity	NULL
to	NULL
cotransfected	NULL
growth	NULL
hormone	NULL
levels	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
CBP	NULL
(	NULL
4	NULL
)	NULL
,	NULL
p300	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
P/CAF	NULL
(	NULL
1D	NULL
)	NULL
are	NULL
shown	NULL
along	NULL
with	NULL
a	NULL
dose-response	NULL
test	NULL
of	NULL
CBP	NULL
(	NULL
B	NULL
)	NULL
.	NULL

differentiating	NULL
tissues	NULL
(	NULL
28	NULL
,	NULL
37	NULL
)	NULL
.	NULL

An	NULL
alternative	NULL
explanation	NULL
is	NULL
that	NULL
a	NULL
high	NULL
level	NULL
of	NULL
P/CAF	NULL
expression	NULL
simply	NULL
interferes	NULL
with	NULL
EKLEF	NULL
's	NULL
interaction	NULL
with	NULL
CBP	NULL
or	NULL
p300	NULL
.	NULL

P/CAF	NULL
interacts	NULL
with	NULL
CBP	NULL
within	NULL
the	NULL
same	NULL
region	NULL
as	NULL
E1A	NULL
(	NULL
28	NULL
)	NULL
,	NULL
and	NULL
such	NULL
interference	NULL
would	NULL
imply	NULL
that	NULL
EKLF	NULL
interacts	NULL
there	NULL
also	NULL
.	NULL

Although	NULL
we	NULL
have	NULL
not	NULL
directly	NULL
investigated	NULL
which	NULL
regions	NULL
of	NULL
EKLF	NULL
associate	NULL
with	NULL
p300/CBP	NULL
,	NULL
the	NULL
interaction	NULL
must	NULL
be	NULL
complex	NULL
,	NULL
as	NULL
GST	NULL
constructs	NULL
that	NULL
contain	NULL
only	NULL
the	NULL
transactivation	NULL
region	NULL
(	NULL
amino	NULL
acids	NULL
20-291	NULL
)	NULL
or	NULL
primarily	NULL
the	NULL
zinc	NULL
finger	NULL
region	NULL
(	NULL
amino	NULL
acids	NULL
287-376	NULL
)	NULL
are	NULL
each	NULL
suitable	NULL
substrates	NULL
for	NULL
acetylation	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
putative	NULL
acetylated	NULL
lysines	NULL
279	NULL
and	NULL
288	NULL
map	NULL
to	NULL
the	NULL
EKLF	NULL
inhibitory	NULL
domain	NULL
,	NULL
which	NULL
acts	NULL
in	NULL
cis	NULL
and	NULL
is	NULL
the	NULL
highly	NULL
basic	NULL
portion	NULL
of	NULL
the	NULL
trans-activation	NULL
region	NULL
(	NULL
19	NULL
)	NULL
.	NULL

These	NULL
lysines	NULL
also	NULL
overlap	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
that	NULL
is	NULL
common	NULL
to	NULL
EKLF	NULL
,	NULL
gut-enriched	NULL
Kriippel-like	NULL
factor	NULL
(	NULL
GKLF	NULL
)	NULL
,	NULL
and	NULL
lung	NULL
Kriippel-like	NULL
factor	NULL
(	NULL
LKLF	NULL
)	NULL
(	NULL
39	NULL
)	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
,	NULL
not	NULL
only	NULL
is	NULL
the	NULL
distance	NULL
between	NULL
these	NULL
two	NULL
lysines	NULL
constant	NULL
in	NULL
this	NULL
related	NULL
family	NULL
,	NULL
but	NULL
the	NULL
locations	NULL
of	NULL
flanking	NULL
arginines	NULL
(	NULL
amino	NULL
acid	NULL
residues	NULL
280	NULL
,	NULL
282	NULL
,	NULL
283	NULL
,	NULL
289	NULL
)	NULL
are	NULL
also	NULL
conserved	NULL
.	NULL

Intrigu-ingly	NULL
,	NULL
the	NULL
distance	NULL
between	NULL
acetylated	NULL
lysines	NULL
in	NULL
p53	NULL
(	NULL
K373	NULL
and	NULL
K382	NULL
)	NULL
is	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
EKLF	NULL
,	NULL
and	NULL
this	NULL
region	NULL
also	NULL
contains	NULL
a	NULL
conserved	NULL
arginine	NULL
residue	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
have	NULL
not	NULL
observed	NULL
any	NULL
effect	NULL
of	NULL
acetylation	NULL
on	NULL
EKLF	NULL
DNA	NULL
binding	NULL
in	NULL
vitro	NULL
by	NULL
gel-shift	NULL
analysis	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
,	NULL
such	NULL
effects	NULL
may	NULL
be	NULL
subtle	NULL
and	NULL
not	NULL
readily	NULL
apparent	NULL
when	NULL
using	NULL
Biochemistry	NULL
:	NULL
Zhang	NULL
and	NULL
Bicker	NULL
GST-EKLF	NULL
fusions	NULL
.	NULL

Whether	NULL
acetylation	NULL
affects	NULL
nuclear	NULL
trans-location	NULL
awaits	NULL
analysis	NULL
,	NULL
as	NULL
these	NULL
two	NULL
processes	NULL
have	NULL
not	NULL
been	NULL
linked	NULL
previously	NULL
.	NULL

It	NULL
is	NULL
now	NULL
clear	NULL
that	NULL
EKLF	NULL
undergoes	NULL
two	NULL
types	NULL
of	NULL
post-translational	NULL
modifications	NULL
:	NULL
phosphorylation	NULL
and	NULL
acetylation	NULL
.	NULL

Phosphorylation	NULL
of	NULL
Thr-41	NULL
within	NULL
the	NULL
activation	NULL
domain	NULL
is	NULL
critical	NULL
for	NULL
EKLF	NULL
trans-activation	NULL
in	NULL
vivo	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Unlike	NULL
the	NULL
inhibitory	NULL
domain	NULL
,	NULL
the	NULL
minimal	NULL
activation	NULL
domain	NULL
acts	NULL
in	NULL
trans	NULL
,	NULL
is	NULL
acidic	NULL
,	NULL
and	NULL
is	NULL
located	NULL
at	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
the	NULL
EKLF	NULL
transactivation	NULL
region	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Our	NULL
present	NULL
studies	NULL
show	NULL
that	NULL
EKLF	NULL
activity	NULL
may	NULL
also	NULL
be	NULL
augmented	NULL
by	NULL
acetylation	NULL
.	NULL

Altered	NULL
levels	NULL
of	NULL
EKLF	NULL
phosphorylation	NULL
and	NULL
acetylation	NULL
may	NULL
provide	NULL
two	NULL
distinct	NULL
yet	NULL
overlapping	NULL
forms	NULL
of	NULL
cellular	NULL
control	NULL
over	NULL
its	NULL
activity	NULL
during	NULL
erythroid	NULL
ontogeny	NULL
.	NULL

If	NULL
these	NULL
types	NULL
of	NULL
control	NULL
mechanisms	NULL
are	NULL
primarily	NULL
operative	NULL
in	NULL
definitive	NULL
cells	NULL
,	NULL
this	NULL
may	NULL
explain	NULL
how	NULL
EKLF	NULL
is	NULL
required	NULL
for	NULL
completion	NULL
of	NULL
the	NULL
definitive	NULL
erythroid	NULL
program	NULL
,	NULL
even	NULL
though	NULL
it	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
primitive	NULL
erythroid	NULL
cells	NULL
(	NULL
29	NULL
)	NULL
and	NULL
in	NULL
multipotent	NULL
progenitors	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Biological	NULL
Implications	NULL
of	NULL
EKLF	NULL
Acetylation	NULL
.	NULL

HATs	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
maintenance	NULL
of	NULL
the	NULL
open	NULL
chromatin	NULL
configuration	NULL
seen	NULL
at	NULL
the	NULL
B-globin	NULL
locus	NULL
,	NULL
as	NULL
acetylated	NULL
histones	NULL
are	NULL
preferentially	NULL
distributed	NULL
throughout	NULL
the	NULL
region	NULL
in	NULL
erythroid	NULL
cells	NULL
(	NULL
23	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
treatment	NULL
of	NULL
erythroid	NULL
cells	NULL
with	NULL
butyrate	NULL
(	NULL
43	NULL
)	NULL
or	NULL
TSA	NULL
(	NULL
44	NULL
)	NULL
alters	NULL
the	NULL
expression	NULL
profile	NULL
of	NULL
the	NULL
globin	NULL
genes	NULL
within	NULL
the	NULL
locus	NULL
.	NULL

The	NULL
present	NULL
experiments	NULL
reveal	NULL
that	NULL
HAT	NULL
's	NULL
may	NULL
exert	NULL
a	NULL
second	NULL
effect	NULL
on	NULL
expression	NULL
within	NULL
the	NULL
locus	NULL
by	NULL
their	NULL
ability	NULL
to	NULL
acetylate	NULL
critical	NULL
erythroid-specific	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
EKLF	NULL
and	NULL
affect	NULL
their	NULL
function	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
idea	NULL
,	NULL
TSA	NULL
acts	NULL
as	NULL
an	NULL
inducer	NULL
of	NULL
globin	NULL
synthesis	NULL
in	NULL
MEL	NULL
cells	NULL
(	NULL
45	NULL
)	NULL
,	NULL
and	NULL
conversely	NULL
,	NULL
interference	NULL
(	NULL
by	NULL
E1A	NULL
repression	NULL
)	NULL
of	NULL
CBP	NULL
activity	NULL
in	NULL
MEL	NULL
cells	NULL
prevents	NULL
induction	NULL
of	NULL
globin	NULL
expression	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Our	NULL
present	NULL
experiments	NULL
utilized	NULL
transient	NULL
transfection	NULL
to	NULL
test	NULL
for	NULL
functional	NULL
effects	NULL
of	NULL
HAT	NULL
's	NULL
on	NULL
EKLF	NULL
activity	NULL
.	NULL

Although	NULL
the	NULL
actual	NULL
chromatin	NULL
status	NULL
of	NULL
these	NULL
templates	NULL
is	NULL
not	NULL
known	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
a	NULL
loose	NULL
and	NULL
disorganized	NULL
structure	NULL
(	NULL
47	NULL
)	NULL
.	NULL

In	NULL
this	NULL
sense	NULL
,	NULL
one	NULL
may	NULL
speculate	NULL
that	NULL
acetylation	NULL
of	NULL
histones	NULL
is	NULL
not	NULL
the	NULL
dominant	NULL
cause	NULL
of	NULL
EKLF	NULL
superactivity	NULL
in	NULL
transient	NULL
assays	NULL
,	NULL
and	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
p300	NULL
and	NULL
CBP	NULL
on	NULL
EKLF	NULL
activity	NULL
arises	NULL
from	NULL
their	NULL
function	NULL
as	NULL
bridging	NULL
factors	NULL
and/or	NULL
as	NULL
FAT	NULL
's	NULL
.	NULL

However	NULL
,	NULL
CBP	NULL
may	NULL
also	NULL
be	NULL
affecting	NULL
other	NULL
parts	NULL
of	NULL
the	NULL
transcriptional	NULL
process	NULL
,	NULL
including	NULL
bridging	NULL
with	NULL
and/or	NULL
modification	NULL
of	NULL
other	NULL
target	NULL
proteins	NULL
important	NULL
for	NULL
full	NULL
activity	NULL
of	NULL
the	NULL
B-globin	NULL
promoter	NULL
.	NULL

Although	NULL
the	NULL
functional	NULL
effects	NULL
of	NULL
TFIIERB	NULL
and	NULL
TFIIH	NULL
modification	NULL
are	NULL
not	NULL
known	NULL
,	NULL
acetylation	NULL
of	NULL
p53	NULL
alters	NULL
its	NULL
conformation	NULL
,	NULL
increasing	NULL
its	NULL
DNA-binding	NULL
affinity	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Acetylation	NULL
of	NULL
histones	NULL
decreases	NULL
the	NULL
affinity	NULL
of	NULL
their	NULL
amino-terminal	NULL
tails	NULL
for	NULL
DNA	NULL
,	NULL
altering	NULL
chromatin	NULL
structure	NULL
(	NULL
reviewed	NULL
in	NULL
ref	NULL
.	NULL

21	NULL
)	NULL
.	NULL

By	NULL
analogy	NULL
,	NULL
EKLF	NULL
acetylation	NULL
would	NULL
be	NULL
predicted	NULL
to	NULL
affect	NULL
its	NULL
protein-protein	NULL
or	NULL
protein-DNA	NULL
interactions	NULL
as	NULL
a	NULL
result	NULL
of	NULL
neutralizing	NULL
positively	NULL
charged	NULL
lysines	NULL
.	NULL

Given	NULL
that	NULL
EKLF	NULL
is	NULL
acetylated	NULL
and	NULL
that	NULL
its	NULL
transcriptional	NULL
activity	NULL
is	NULL
stimulated	NULL
by	NULL
CBP/p300	NULL
,	NULL
it	NULL
is	NULL
more	NULL
likely	NULL
that	NULL
intra-	NULL
or	NULL
intermolecular	NULL
protein	NULL
interactions	NULL
,	NULL
rather	NULL
than	NULL
those	NULL
with	NULL
DNA	NULL
,	NULL
are	NULL
affected	NULL
.	NULL

This	NULL
may	NULL
result	NULL
in	NULL
a	NULL
cascade	NULL
of	NULL
interactions	NULL
that	NULL
would	NULL
explain	NULL
the	NULL
requirement	NULL
of	NULL
EKLF	NULL
for	NULL
formation	NULL
of	NULL
DNase-sensitive	NULL
sites	NULL
at	NULL
the	NULL
adult	NULL
B-globin	NULL
promoter	NULL
and	NULL
at	NULL
HS3	NULL
(	NULL
17	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
EKLF	NULL
may	NULL
recruit	NULL
CBP	NULL
to	NULL
the	NULL
-globin	NULL
promoter	NULL
,	NULL
resulting	NULL
in	NULL
modification	NULL
of	NULL
the	NULL
local	NULL
core	NULL
histones	NULL
and	NULL
of	NULL
EKLF	NULL
,	NULL
which	NULL
may	NULL
then	NULL
be	NULL
further	NULL
able	NULL
to	NULL
recruit	NULL
a	NULL
chromatin	NULL
remodeling	NULL
complex	NULL
that	NULL
decondenses	NULL
the	NULL
area	NULL
and	NULL
renders	NULL
it	NULL
transcriptionally	NULL
competent	NULL
.	NULL

In	NULL
support	NULL
of	NULL
such	NULL
an	NULL
idea	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
EKLF	NULL
to	NULL
activate	NULL
in	NULL
vitro	NULL
transcription	NULL
of	NULL
a	NULL
chromatin-repressed	NULL
B-globin	NULL
promoter	NULL
requires	NULL
a	NULL
SWI/SNF-like	NULL
remodeling	NULL
complex	NULL
(	NULL
J.	NULL
Armstrong	NULL
,	NULL
J.J.B	NULL
.	NULL

,	NULL
and	NULL
B.	NULL
Emerson	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
histone	NULL
acety-lase	NULL
ADA/GCNS5	NULL
and	NULL
the	NULL
chromatin	NULL
remodeling	NULL
SWI/SNF	NULL
complex	NULL
are	NULL
thought	NULL
to	NULL
act	NULL
in	NULL
concert	NULL
to	NULL
modify	NULL
chromatin	NULL
structure	NULL
at	NULL
specific	NULL
target	NULL
genes	NULL
in	NULL
yeast	NULL
(	NULL
48	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
9859	NULL
CBP	NULL
/p300	NULL
interacts	NULL
with	NULL
BRG1	NULL
,	NULL
a	NULL
human	NULL
homolog	NULL
of	NULL
SWI2	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Such	NULL
a	NULL
coordinate	NULL
acetylation/remodeling	NULL
mechanism	NULL
has	NULL
been	NULL
postulated	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
long-distance	NULL
regulation	NULL
of	NULL
the	NULL
B-like	NULL
globin	NULL
cluster	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Clearly	NULL
,	NULL
future	NULL
experiments	NULL
will	NULL
be	NULL
directed	NULL
at	NULL
resolving	NULL
whether	NULL
and	NULL
how	NULL
EKLF	NULL
acts	NULL
as	NULL
an	NULL
integrator	NULL
of	NULL
these	NULL
various	NULL
signals	NULL
at	NULL
the	NULL
adult	NULL
-globin	NULL
locus	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
.	NULL

Xiaoyong	NULL
Chen	NULL
and	NULL
Checco	NULL
Ramirez	NULL
for	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
,	NULL
Dr.	NULL
Tom	NULL
Moran	NULL
for	NULL
help	NULL
in	NULL
raising	NULL
anti-EKLF	NULL
monoclonal	NULL
antibodies	NULL
,	NULL
and	NULL
Drs	NULL
.	NULL

Liaohan	NULL
Ouyang	NULL
,	NULL
Yoshihiro	NULL
Nakatani	NULL
,	NULL
Richard	NULL
Goodman	NULL
,	NULL
Ronald	NULL
Kwok	NULL
,	NULL
David	NULL
Livingston	NULL
,	NULL
and	NULL
Tim	NULL
Townes	NULL
for	NULL
reagents	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
Grant	NULL
DK46865	NULL
to	NULL
J.J.B	NULL
.	NULL

,	NULL
who	NULL
is	NULL
a	NULL
Scholar	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

This	NULL
is	NULL
manuscript	NULL
267	NULL
from	NULL
the	NULL
Brookdale	NULL
Center	NULL
for	NULL
Molecular	NULL
Biology	NULL
at	NULL
the	NULL
Mount	NULL
Sinai	NULL
School	NULL
of	NULL
Medicine	NULL
.	NULL

1	NULL
.	NULL

Townes	NULL
,	NULL
T.	NULL
M.	NULL
&	NULL
Behringer	NULL
,	NULL
R.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

6	NULL
,	NULL
219-223	NULL
.	NULL

Felsenfeld	NULL
,	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
355	NULL
,	NULL
219-224	NULL
.	NULL

Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

9	NULL
,	NULL
304-309	NULL
.	NULL

Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

231	NULL
,	NULL
271-281	NULL
.	NULL

Martin	NULL
,	NULL
D.	NULL
I.	NULL
K.	NULL
,	NULL
Fiering	NULL
,	NULL
S.	NULL
&	NULL
Groudine	NULL
,	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

6	NULL
,	NULL
488-495	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Baron	NULL
,	NULL
M.	NULL
H.	NULL
(	NULL
1997	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1351	NULL
,	NULL
51-72	NULL
.	NULL

7	NULL
.	NULL

Fraser	NULL
,	NULL
P.	NULL
,	NULL
Gribnau	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Trimborn	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Curr	NULL
Opin	NULL
.	NULL

Hematol	NULL
.	NULL

5	NULL
,	NULL
139-144	NULL
.	NULL

8	NULL
.	NULL

Bieker	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Hematol	NULL
.	NULL

5	NULL
,	NULL
145-150	NULL
.	NULL

9	NULL
.	NULL

Miller	NULL
,	NULL
I.	NULL
J	NULL
.	NULL

&	NULL
Bieker	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
2776-2786	NULL
.	NULL

10	NULL
.	NULL

-	NULL
Bieker	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
in	NULL
Molecular	NULL
Biology	NULL
of	NULL
Hemoglobin	NULL
Switching	NULL
,	NULL
ed	NULL
.	NULL

Stamatoyannopoulos	NULL
,	NULL
G.	NULL
(	NULL
Intercept	NULL
,	NULL
Andover	NULL
,	NULL
U.K.	NULL
)	NULL
,	NULL
Vol	NULL
.	NULL

1	NULL
,	NULL
pp	NULL
.	NULL

231-241	NULL
.	NULL

11	NULL
.	NULL

Feng	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Southwood	NULL
,	NULL
C.	NULL
M.	NULL
&	NULL
Bicker	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
BioL	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
1493-1500	NULL
.	NULL

12	NULL
.	NULL

Donze	NULL
,	NULL
D.	NULL
,	NULL
Townes	NULL
,	NULL
T.	NULL
M.	NULL
&	NULL
Bieker	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
1955-1959	NULL
.	NULL

13	NULL
.	NULL

Nuez	NULL
,	NULL
B.	NULL
,	NULL
Michalovich	NULL
,	NULL
D.	NULL
,	NULL
Bygrave	NULL
,	NULL
A.	NULL
,	NULL
Ploemacher	NULL
,	NULL
R.	NULL
&	NULL
Grosveld	NULL
,	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
375	NULL
,	NULL
316-318	NULL
.	NULL

14	NULL
.	NULL

Perkins	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Sharpe	NULL
,	NULL
A.	NULL
H.	NULL
&	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
375	NULL
,	NULL
318-322	NULL
.	NULL

15	NULL
.	NULL

Lim	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Bicker	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Lin	NULL
,	NULL
C.	NULL
S.	NULL
&	NULL
Costantini	NULL
,	NULL
F.	NULL
(	NULL
1997	NULL
)	NULL
Blood	NULL
90	NULL
,	NULL
1291-1299	NULL
.	NULL

16	NULL
.	NULL

Perkins	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Gaensler	NULL
,	NULL
K.	NULL
M.	NULL
L.	NULL
&	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
,	NULL
12267-12271	NULL
.	NULL

17	NULL
.	NULL

Wijgerde	NULL
,	NULL
M.	NULL
,	NULL
Gribnau	NULL
,	NULL
J.	NULL
,	NULL
Trimborn	NULL
,	NULL
T.	NULL
,	NULL
Nuez	NULL
,	NULL
B.	NULL
,	NULL
Philipsen	NULL
,	NULL
S.	NULL
,	NULL
Grosveld	NULL
,	NULL
F.	NULL
&	NULL
Fraser	NULL
,	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

10	NULL
,	NULL
2894-2902	NULL
.	NULL

18	NULL
.	NULL

Bieker	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

&	NULL
Southwood	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
852-860	NULL
.	NULL

19	NULL
.	NULL

Chen	NULL
,	NULL
X	NULL
.	NULL

&	NULL
Bicker	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
5888-5896	NULL
.	NULL

20	NULL
.	NULL

Wu	NULL
,	NULL
C.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
28171-28174	NULL
.	NULL

21	NULL
.	NULL

Wade	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Pruss	NULL
,	NULL
D.	NULL
&	NULL
Wolffe	NULL
,	NULL
A.	NULL
P.	NULL
(	NULL
1997	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

22	NULL
,	NULL
128-132	NULL
.	NULL

22	NULL
.	NULL

Struhl	NULL
,	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

12	NULL
,	NULL
599-606	NULL
.	NULL

23	NULL
.	NULL

Hebbes	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
Clayton	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Thorne	NULL
,	NULL
A.	NULL
W.	NULL
&	NULL
Crane-Robinson	NULL
,	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
1823-1830	NULL
.	NULL

24	NULL
.	NULL

Chrivia	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Kwok	NULL
,	NULL
R.	NULL
P.	NULL
S.	NULL
,	NULL
Lamb	NULL
,	NULL
N.	NULL
,	NULL
Hagiwara	NULL
,	NULL
M.	NULL
,	NULL
Montminy	NULL
,	NULL
M.	NULL
R.	NULL
&	NULL
Goodman	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
365	NULL
,	NULL
855-859	NULL
.	NULL

25	NULL
.	NULL

Janknecht	NULL
,	NULL
R.	NULL
&	NULL
Hunter	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
383	NULL
,	NULL
22-23	NULL
.	NULL

26	NULL
.	NULL

Wolffe	NULL
,	NULL
A.	NULL
P.	NULL
&	NULL
Pruss	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
84	NULL
,	NULL
817-819	NULL
.	NULL

27	NULL
.	NULL

Gu	NULL
,	NULL
W.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
Cell	NULL
90	NULL
,	NULL
595-606	NULL
.	NULL

28	NULL
.	NULL

Yang	NULL
,	NULL
X.	NULL
J.	NULL
,	NULL
Ogryzko	NULL
,	NULL
V.	NULL
V.	NULL
,	NULL
Nishikawa	NULL
,	NULL
J.	NULL
,	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
&	NULL
Nakatani	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
382	NULL
,	NULL
319-324	NULL
.	NULL

29	NULL
.	NULL

-	NULL
Southwood	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Downs	NULL
,	NULL
K.	NULL
M.	NULL
&	NULL
Bicker	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Dev	NULL
.	NULL

Dyn	NULL
.	NULL

206	NULL
,	NULL
248-259	NULL
.	NULL

30	NULL
.	NULL

Eckner	NULL
,	NULL
R.	NULL
,	NULL
Ewen	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Newsome	NULL
,	NULL
D.	NULL
,	NULL
Gerdes	NULL
,	NULL
M.	NULL
,	NULL
DeCaprio	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Lawrence	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

&	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
869-884	NULL
.	NULL

31	NULL
.	NULL

Kwok	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Laurance	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Lundblad	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Goldman	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Shih	NULL
,	NULL
H.	NULL
,	NULL
Connor	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Marriott	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

&	NULL
Goodman	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
380	NULL
,	NULL
642-646	NULL
.	NULL

32	NULL
.	NULL

Caterina	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Ciavatta	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Donze	NULL
,	NULL
D.	NULL
,	NULL
Behringer	NULL
,	NULL
R.	NULL
R.	NULL
&	NULL
Townes	NULL
,	NULL
T.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
1006-1011	NULL
.	NULL

33	NULL
.	NULL

Bannister	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

&	NULL
Kouzarides	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
384	NULL
,	NULL
641-643.	NULL
ip	NULL
topo	NULL
9860	NULL
34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

Biochemistry	NULL
:	NULL
Zhang	NULL
and	NULL
Bicker	NULL
Shikama	NULL
,	NULL
N.	NULL
,	NULL
Lyon	NULL
,	NULL
J	NULL
.	NULL

&	NULL
LaThangue	NULL
,	NULL
N.	NULL
B	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Trends	NULL
Cell	NULL
Biol	NULL
.	NULL

7	NULL
,	NULL
230-237	NULL
.	NULL

Imhof	NULL
,	NULL
A.	NULL
,	NULL
Yang	NULL
,	NULL
X.	NULL
J.	NULL
,	NULL
Ogryzko	NULL
,	NULL
V.	NULL
V.	NULL
,	NULL
Nakatani	NULL
,	NULL
Y.	NULL
,	NULL
Wolffe	NULL
,	NULL
A.	NULL
P.	NULL
&	NULL
Ge	NULL
,	NULL
H.	NULL
(	NULL
1997	NULL
)	NULL
Curr	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
689-692	NULL
.	NULL

Bieker	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
DNA	NULL
Cell	NULL
Biol	NULL
.	NULL

15	NULL
,	NULL
347-352	NULL
.	NULL

Puri	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Sartorelli	NULL
,	NULL
V.	NULL
,	NULL
Yang	NULL
,	NULL
X.	NULL
J.	NULL
,	NULL
Hamamori	NULL
,	NULL
Y.	NULL
,	NULL
Ogryzko	NULL
,	NULL
V.	NULL
V.	NULL
,	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
Kedes	NULL
,	NULL
L.	NULL
,	NULL
Wang	NULL
,	NULL
J.	NULL
Y.	NULL
J.	NULL
,	NULL
Graessmann	NULL
,	NULL
A.	NULL
,	NULL
Nakatani	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Levrero	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Molecular	NULL
Cell	NULL
1	NULL
,	NULL
35-45	NULL
.	NULL

Korzus	NULL
,	NULL
E.	NULL
,	NULL
Torchia	NULL
,	NULL
J.	NULL
,	NULL
Rose	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Xu	NULL
,	NULL
L.	NULL
,	NULL
Kurokawa	NULL
,	NULL
R.	NULL
,	NULL
McInerney	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Mullen	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Glass	NULL
,	NULL
C.	NULL
K.	NULL
&	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
(	NULL
1998	NULL
)	NULL
Science	NULL
279	NULL
,	NULL
703-707	NULL
.	NULL

Shields	NULL
,	NULL
J.	NULL
M.	NULL
&	NULL
Yang	NULL
,	NULL
V.	NULL
W.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
18504-18507	NULL
.	NULL

Ouyang	NULL
,	NULL
L.	NULL
,	NULL
Chen	NULL
,	NULL
X	NULL
.	NULL

&	NULL
Bieker	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Hu	NULL
,	NULL
M.	NULL
,	NULL
Krause	NULL
,	NULL
D.	NULL
,	NULL
Greaves	NULL
,	NULL
M.	NULL
,	NULL
Sharkis	NULL
,	NULL
S.	NULL
,	NULL
Dexter	NULL
,	NULL
M.	NULL
,	NULL
Heyworth	NULL
,	NULL
C.	NULL
&	NULL
Enver	NULL
,	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

11	NULL
,	NULL
774-785	NULL
.	NULL

Reese	NULL
,	NULL
T.	NULL
T.	NULL
,	NULL
Gregory	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Sharlow	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
Pacifici	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Crouse	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Todokoro	NULL
,	NULL
K.	NULL
&	NULL
Wojchowski	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Growth	NULL
Factors	NULL
14	NULL
,	NULL
161-176	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
Stamatoyannopoulos	NULL
,	NULL
G.	NULL
&	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Med	NULL
.	NULL

43	NULL
,	NULL
497-521	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Newsome	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Fibach	NULL
,	NULL
E.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
&	NULL
Su	NULL
,	NULL
M.	NULL
S.	NULL
S.	NULL
(	NULL
1997	NULL
)	NULL
Blood	NULL
90	NULL
,	NULL
2075-2083	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Nomura	NULL
,	NULL
S.	NULL
&	NULL
Beppu	NULL
,	NULL
T.	NULL
(	NULL
1987	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

47	NULL
,	NULL
3688-3691	NULL
.	NULL

Blobel	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Nakajima	NULL
,	NULL
T.	NULL
,	NULL
Eckner	NULL
,	NULL
R.	NULL
,	NULL
Montminy	NULL
,	NULL
M.	NULL
&	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
,	NULL
2061-2066	NULL
.	NULL

Smith	NULL
,	NULL
C.	NULL
L.	NULL
&	NULL
Hager	NULL
,	NULL
G.	NULL
L.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
27493-27496	NULL
.	NULL

Pollard	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

&	NULL
Peterson	NULL
,	NULL
C.	NULL
L.	NULL
(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17	NULL
,	NULL
6212-6222	NULL
.	NULL

Dallas	NULL
,	NULL
P.	NULL
B.	NULL
,	NULL
Yaciuk	NULL
,	NULL
P.	NULL
&	NULL
Moran	NULL
,	NULL
E.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Virol	NULL
71	NULL
,	NULL
1726-1731	NULL
.	NULL

Bresnick	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Versaw	NULL
,	NULL
W.	NULL
K.	NULL
,	NULL
Lam	NULL
,	NULL
L.	NULL
T.	NULL
,	NULL
Forsberg	NULL
,	NULL
E.	NULL
C.	NULL
&	NULL
Eisenman	NULL
,	NULL
H.	NULL
C.	NULL
(	NULL
1997	NULL
)	NULL
in	NULL
Gene	NULL
Therapy	NULL
and	NULL
Molecular	NULL
Biology	NULL
:	NULL
From	NULL
Basic	NULL
Mechanisms	NULL
to	NULL
Clinical	NULL
Applications	NULL
,	NULL
ed	NULL
.	NULL

Boulikas	NULL
,	NULL
T.	NULL
(	NULL
Gene	NULL
Therapy	NULL
Press	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
Vol	NULL
.	NULL

1	NULL
,	NULL
pp	NULL
.	NULL

483-494	NULL
.	NULL

